Early personalized prediction for better brain health

Prodromic predicts disease trajectory early

Multimodal AI

We tackle the complexity of the brain by integrating different data sources

Designed for integration into trials and clinical workflows

Our AI approach is robust and explainable to provide the foundations for trust

Real world solutions

Responsible by design

Dementia steals people and costs lives

A vast personal and societal problem ...

• Every 3 seconds someone new is diagnosed with dementia

• $1.3 Trillion cost to the global economy

• 3x more cases by 2050

... desperately in need of new solutions

• >95% failure rate for late-stage clinical trials

• >$43B pharma investment over 30 years

• "Approved - not used" - recent drugs withdrawn / challenged in market

Our technology stratifies patients “ahead of the clinic" to unlock new treatments and personalise care for each individual

Our mission:

No one dies from Alzheimer's by 2050

We're building partnerships to accelerate new treatments

Diseases such as dementia have huge human and societal cost. Progress in new treatments has been slow because we've been testing promising new drugs on (a) the wrong patients and (b) the right patients at the wrong time.

We're working with clinicians, academics and pharmaceutical developers to accelerate the fight against brain diseases. By identifying the right patients earlier in disease, our solutions make clinical trials faster, lower-cost, and more effective.